About
Speakers
Digital Content Hub
Agenda
About
Speakers
Digital Content Hub
Agenda
JOIN NOW
JOIN NOW
monday, July 26th, 2021 | 1 - 3 pm ct
oncology virtual forum
The COVID-19 pandemic disrupted cancer screenings, care delivery and research. But the disease did not slow down. Experts anticipate patients will seek treatment for more advanced-stage cancers than in the past, and oncology centers across the U.S. are making preparations. Clinicians and researchers are also redesigning the cancer patient journey, developing more sophisticated therapies and relying on cutting-edge technology to take cancer treatment to the next level. During this event, oncology leaders from top institutions will gather for high-level discussions about the industry and what will happen next.
Stay informed with our virtual learning opportunities. Check out our Webinars, Whitepapers, and our
E-Newsletters today!
Stay Connected
Bhavesh Shah, Senior Director of Hematology and Oncology and Specialty Pharmacy at Boston Medical Center
Katie Struck, System Vice President and Chief Administrative Officer of Oncology at Rush University System for Health
Ken Komorny, Chief Pharmacy Officer at Moffitt Cancer Center
Karen Ignagni, CEO of EmblemHealth
Dr. Donna Havens, Dean and Professor at the College of Nursing at Villanova University and Dr. Peter Kaufmann, Associate Dean of Research and Innovation at the College of Nursing at Villanova University
Podcasts
AGENDA
speakers
digital hub
oncology virtual forum
REGISTER NOW
VIEW ON DEMAND
VIEW ON DEMAND
RSVP NOW
RSVP NOW
Add to Calendar
GMail | Outlook | iCal
SPECIAL THANKS TO OUR CORPORATE SPONSORS:
Copyright © 2021 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.
CONTACT US 1.800.417.2035 | becker@beckershealthcare.com
REGISTER NOW
REGISTER NOW
Craig A Bunnell, MD, MPH, MBA, Chief Medical Officer, Dana-Farber Cancer Institute
Rafael Fonseca, MD, Interim Executive Director, Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator
Steven N. Kalkanis, MD, Chief Executive Officer, Henry Ford Medical Group; Chief Academic Officer, Henry Ford Health System; Henry Ford II Chair and Senior Vice President, Henry Ford Health System
Donna Royster, Administrative Director, Radiation/Oncology, Levine Cancer Institute, Atrium Health
Oncology over the next 5 years: Innovative therapies, telehealth & more
time tba | Panel discussion
View On Demand
View On Demand
Join Session Now
Join Session Now
Join Session Now
Discussion Topics:
• Oncology over the next 5 years: Innovative therapies, telehealth & more
• COVID-19 disrupted cancer screenings. Where do we go from here?
• How to deliver the cancer care patients really want and thrive in a competitive market
Full agenda coming soon!
Craig A Bunnell, MD, MPH, MBA, Chief Medical Officer, Dana-Farber Cancer Institute
Rafael Fonseca, MD, Interim Executive Director, Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator
Steven N. Kalkanis, MD, Chief Executive Officer, Henry Ford Medical Group; Chief Academic Officer, Henry Ford Health System; Henry Ford II Chair and Senior Vice President, Henry Ford Health System
Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Professor of Medicine, Cleveland Clinic Lerner School of Medicine
thank you to our sponsors:
Speaker information coming soon!
COVID-19 disrupted cancer screenings. Where do we go from here?
Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Professor of Medicine, Levine Cancer Institute; Professor of Medicine and Pediatrics, Atrium Health
Jeff Wright, University of Kansas Health System, Vice President of Cancer Services
Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School
Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Assistant Professor, Breast and Endocrine Surgery, University of Massachusetts Medical School
time tba | Panel discussion
View On Demand
View On Demand
Join Session Now
Join Session Now
Join Session Now
How to deliver the cancer care patients really want and thrive in a competitive market
Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Professor of Medicine, Cleveland Clinic Lerner School of Medicine
Ed Edwards, Director of Materials Management, MD Anderson Cancer Center
Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School
Tatjana Kolevska, MD, Medical Director, Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group
time tba | Panel discussion
View On Demand
View On Demand
Join Session Now
Join Session Now
Join Session Now
Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School
Ed Edwards, Director of Materials Management, MD Anderson Cancer Center
Jeff Wright, University of Kansas Health System, Vice President of Cancer Services
Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Professor of Medicine, Levine Cancer Institute; Professor of Medicine and Pediatrics, Atrium Health
Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Assistant Professor, Breast and Endocrine Surgery, University of Massachusetts Medical School
Donna Royster, Administrative Director, Radiation/Oncology, Levine Cancer Institute, Atrium Health
Tatjana Kolevska, MD, Medical Director, Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group
RSVP NOW
RSVP NOW
JOIN NOW
JOIN NOW
VIEW ON DEMAND
VIEW ON DEMAND
Copyright © 2021 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.
CONTACT US 1.800.417.2035 | becker@beckershealthcare.com
Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering
Fireside Chat: Cancer Health Equity
Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan
time tba | FIRESIDE CHAT
View On Demand
View On Demand
Join Session Now
Join Session Now
Join Session Now
About
Speakers
Digital Content Hub
Agenda
About
Speakers
Digital Content Hub
Agenda
JOIN NOW
JOIN NOW
VIEW ON DEMAND
VIEW ON DEMAND
RSVP NOW
RSVP NOW
Copyright © 2021 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.
CONTACT US 1.800.417.2035 | becker@beckershealthcare.com
Session description
Attendees will learn about how virtual health can:
• Expand consumer and clinician access
• Improve clinical outcome
• Enhance consumer experience
Bill Fera, MD, Principal, Deloitte Consulting LLP
Ken Abrams, MD, Consulting Managing Director, Deloitte Consulting, LLP
Urvi Shah, Senior Manager, Deloitte Consulting LLP
session title
SPONSORED BY:
Copyright © 2021 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.
CONTACT US 1.800.417.2035 | becker@beckershealthcare.com
Session description
Attendees will learn about how virtual health can:
• Expand consumer and clinician access
• Improve clinical outcome
• Enhance consumer experience
Bill Fera, MD, Principal, Deloitte Consulting LLP
Ken Abrams, MD, Consulting Managing Director, Deloitte Consulting, LLP
Urvi Shah, Senior Manager, Deloitte Consulting LLP
session title
SPONSORED BY:
RSVP NOW
RSVP NOW
JOIN NOW
JOIN NOW
VIEW ON DEMAND
VIEW ON DEMAND
